Wilmington, Delaware, United States, July 18, 2022 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - Analysis of smoking cessation industry statistics over the past few decades has found that rise in use of prescription as well as OTC products to help smokers quit smoking, which mainly include skin patches and gums. The smoking cessation and nicotine de-addiction market is projected to reach US$ 27.84 Bn in 2031. The target population is becoming aware of the health burden of cigarette smoking in that smoking-related diseases cause premature deaths every year.
Innovative marketing campaign for the availability and effectiveness of various smoking cessation products have bolstered their awareness of smoking cessation benefits, thus expanding the canvas for companies in the smoking cessation and nicotine de-addiction market. National research agencies in the U.S. and the U.K. are massively supporting tobacco-related disease research. As a result of these factors and market trends, smoking cessation programs have grown notably in Europe, expanding the smoking cessation market size.
A spate of studies have underscored the effectiveness of e-cigarettes in smoking cessation therapy, which has broadened the horizon in smoking cessation and nicotine de-addiction market. The number of young adults and adolescents who are serious about quitting smoking has increased significantly over the years. This has expanded profitable avenues for commercializing gum, lozenges, inhalers, nasal sprays, and nicotine patches. Awareness of smoking cessation products through online channels is also increasing among the target population, thus catalyzing growth of smoking cessation and nicotine de-addiction market.
Get PDF Brochure for More Insights - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1849
